Ginkgo Bioworks DNA:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 02/03/23 EST
2.06UNCH (UNCH)
Volume
64,635
Close
2.06quote price arrow down-0.13 (-5.94%)
Volume
20,638,919
52 week range
1.45 - 6.31
Loading...
  • Open2.06
  • Day High2.17
  • Day Low2.00
  • Prev Close2.19
  • 52 Week High6.31
  • 52 Week High Date02/07/22
  • 52 Week Low1.45
  • 52 Week Low Date01/06/23

Key Stats

  • Market Cap3.151B
  • Shares Out1.53B
  • 10 Day Average Volume19.10M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change21.89

KEY STATS

  • Open2.06
  • Day High2.17
  • Day Low2.00
  • Prev Close2.19
  • 52 Week High6.31
  • 52 Week High Date02/07/22
  • 52 Week Low1.45
  • 52 Week Low Date01/06/23
  • Market Cap3.151B
  • Shares Out1.53B
  • 10 Day Average Volume19.10M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change21.89

RATIOS/PROFITABILITY

  • EPS (TTM)-2.24
  • P/E (TTM)-0.92
  • Fwd P/E (NTM)-3.82
  • EBITDA (TTM)-3.608B
  • ROE (TTM)-236.35%
  • Revenue (TTM)527.915M
  • Gross Margin (TTM)54.43%
  • Net Margin (TTM)-670.03%
  • Debt To Equity (MRQ)4.17%

EVENTS

  • Earnings Date03/28/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Ginkgo Bioworks

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Ginkgo Bioworks Holdings, Inc. is engaged in building the horizontal platform for cell programming. The Company's platform is used to program cells on behalf of its customers. Its cell programs are designed to enable biological production of products such as therapeutics, key food ingredients, and chemicals derived from petroleum. The Company operates through two segments: Foundry and Biosecurity. Foundry consists of research and development services performed under...
Jason Kelly
Chief Executive Officer, Founder, Director
Reshma Shetty
President, Founder, Chief Operating Officer, Director
Mark Dmytruk
Chief Financial Officer
Address
27 Drydock Avenue, 8Th Floor
Boston, MA
02210
United States

Top Peers

SYMBOLLASTCHG%CHG
ACAD
ACADIA Pharmaceuticals Inc
19.83-0.08-0.40%
GH
Guardant Health Inc
31.94-0.45-1.39%
FOLD
Amicus Therapeutics Inc
13.25-0.26-1.92%
ABCL
Abcellera Biologics Inc
11.18+0.17+1.54%
GLPG
Galapagos NV
42.42-0.98-2.26%